Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2003-5-16
pubmed:abstractText
The design and synthesis of novel pyrrolidine-containing bradykinin antagonists, II, are described. Conformational analysis suggested that a pyrrolidine moiety could substitute for the N-methyl cis-amide moiety of FR 173657. The in vitro binding data showed that the (S)-isomer of II was potent in the bradykinin B(2) receptor-binding assay with a K(i) of 33 nM. The opposite isomer, (R)-II, had a K(i) of 46 nM. The in vitro binding data confirmed our conformational hypothesis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0960-894X
pubmed:author
pubmed:issnType
Print
pubmed:day
2
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1879-82
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Design and synthesis of novel pyrrolidine-containing bradykinin antagonists.
pubmed:affiliation
Drug Discovery, Johnson & Johnson Pharmaceutical Research & Development, Welsh & McKean Roads, PO Box 776, Spring House, PA 19477-0776, USA. jlee@prdus.jnj.com
pubmed:publicationType
Journal Article